Have a personal or library account? Click to login
Influence of different excipients on the properties of hard gelatin capsules with metamizole sodium Cover

Influence of different excipients on the properties of hard gelatin capsules with metamizole sodium

Open Access
|Sep 2016

References

  1. 1. Augsburger L.L. (1996). Hard and soft gelatin capsules. In: Modern Pharmaceutics, 3rd ed. Banker G.S., Rhodes C.T. (editors). New York: Marcel Dekker, Inc.; p. 395.
  2. 2. Basak G.W., Drozd-Sokołowska J., Wiktor-Jedrzejczak W.: Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland. J. Int. Med. Res., 38(4), 1374, 2010.10.1177/147323001003800419
  3. 3. Bowman B.J., Ofner III C.M. (2002). Hard gelatin capsules. In: Protein-Based Films and Coatings. Gennadios A. (editor). Boca Raton: CRC Press; p.367.
  4. 4. Daraghmeh N. et al.: Co-processed chitin-mannitol as a new excipient for oro-dispersible tablets. Mar. Drugs, 13(4), 1739, 2015.10.3390/md13041739
  5. 5. Edwards J. et al.: Single dose dipyrone for acute postoperative pain. Cochrane Database Syst. Rev., 2010. doi:10.1002/14651858.CD003227.pub2.10.1002/14651858.CD003227.pub2
  6. 6. Efentakis M., Vlachou M.: Evaluation of high molecular weight poly(oxyethylene) (Polyox) polymer: studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules. Pharm. Dev. Technol., 5(3), 339, 2000.10.1081/PDT-100100549
  7. 7. European Pharmacopoeia, 7th ed. Strasbourg: Council of Europe, 2010.
  8. 8. Faqih A.M. et al.: Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials. Int. J. Pharm., 336(2), 338, 2007.10.1016/j.ijpharm.2006.12.024
  9. 9. Huber M. et al.: Metamizole-induced agranulocytosis revisited: results from the prospective Berlin case-control surveillance study. Eur. J. Clin. Pharmacol., 71(2), 219, 2015.10.1007/s00228-014-1777-8
  10. 10. Jalil R., Ferdous A.J.: Effect of viscosity increasing agent and electrolyte concentration on the release rate of theophylline from a HPMC based sustained release capsules. Drug Dev. Ind. Pharm., 19(19), 2637, 1993.10.3109/03639049309047206
  11. 11. Kołodziejczyk M.K., Kołodziejska J., Zgoda M.M.: Ibuprofen release preferences of medicinal products, the market share of excipients vermet of a polymer. Polim. Med., 40(4), 19, 2010.
  12. 12. Korzeniowska K., Jankowski J., Jabłecka A.: Nonsteroidal anti-inflammatory drugs. Farm. Współ., 3, 192, 2010.
  13. 13. Lahdenpää E., Niskanen M., Yliruusi J.: Crushing strength, disintegration time and weight variation of tablets compressed from three Avicelä PH grades and their mixtures. Eur. J. Pharm. Biopharm., 43, 315, 1997.
  14. 14. Luukkonen P. et al.: Rheological characterization of microcrystalline cellulose and silicified microcrystalline cellulose wet masses using a mixer torque rheometer. Int. J. Pharm., 188(2), 181, 1999.10.1016/S0378-5173(99)00219-7
  15. 15. Martínez-Martín P. et al.: Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo- and active-controlled, multicentre study. Cephalalgia, 21(5), 604, 2001.
  16. 16. Murtada A.O., Abdelkarim M.A., Huyam A.M.: The effect of sodium starch glycolate concentration on physical effectiveness of chlorpheniramine tablets. Indian J. Pharm. Educ., 4(1), 47, 2013.
  17. 17. Nikolova I. et al.: Metamizole: A review profile of a well-known “forgotten” drug. Part I: Pharmaceutical and nonclinical profile. Biotechnol. Biotechnol. Equip., 26(6), 3329, 2012.
  18. 18. Nokhodchi A. et al.: The role of oral controlled release matrix tablets in drug delivery systems. Bioimpacts, 2(4), 175, 2012.
  19. 19. Overguard A.B.A. et al.: Patients’ evaluation of shape, size, and color of solid dosage forms. Pharm. World Sci., 23(5), 185, 2001.
  20. 20. Patel R., Podczeck F.: Investigation of the effect of type and source of microcrystalline cellulose on capsule filling. Int. J. Pharm., 128, 123, 1996.
  21. 21. Shah R.B., Tawakkul M.A., Khan M.A.: Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech., 9(1), 250, 2008.10.1208/s12249-008-9046-8297691118446489
  22. 22. Shlieout G., Arnold K., Müller G.: Powder and mechanical properties of microcrystalline cellulose with different degrees of polymerization. AAPS PharmSciTech., 3(2), 45, 2002.10.1208/pt030211275031312916948
  23. 23. Stegemann S. (2002). Hard gelatin capsules today –and tomorrow, 2nd ed. Bornem: Capsugel Library.
  24. 24. Zgoda M.M.: Aktualnie stosowane substancje pomocnicze w technologii stałych doustnych środków farmaceutycznych. Farm. Pol., 59(17), 890, 2003.
  25. 25. Zhang P.Y. et al.: Preparation of poly (vinyl butyral) hollow fiber ultrafiltration membrane via wet-spinning method using PVP as additive. Desalination, 278, 186, 2011.10.1016/j.desal.2011.05.026
DOI: https://doi.org/10.1515/cipms-2016-0023 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 114 - 117
Submitted on: Mar 8, 2016
|
Accepted on: Mar 31, 2016
|
Published on: Sep 24, 2016
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Magdalena Rogowska, Karol Iwaniak, Andrzej Polski, Karolina Slawinska, Karolina Sobotka-Polska, Joanna Modrzewska, Ewa Poleszak, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.